Lupin Appoints Claus Jepsen as President, Global Specialty Business
Lupin, a leading drug firm, has appointed Claus Jepsen as President of its Global Specialty business. Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
New Delhi, Oct 21 (PTI) Drug firm Lupin on Monday said it has appointed Claus Jepsen as President, Global Specialty business.
Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.
Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.19 ( -0.49)
- 57919628
- AvanceTechnologies
- 0.64 ( 0.00)
- 25522388
- Standard Capital
- 0.52 ( -3.70)
- 16619978
- GTL Infrastructure
- 1.53 (+ 2.68)
- 15285011
- YES Bank Ltd.
- 17.95 (+ 3.16)
- 12503288
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback